Inhibitors and promoters of thalamic neuron adhesion and outgrowth in embryonic neocortex: Functional association with chondroitin sulfate

Autor: Emerling, DE, Lander, AD

Publikováno v: Emerling, DE; & Lander, AD. (1996). Inhibitors and promoters of thalamic neuron adhesion and outgrowth in embryonic neocortex: Functional association with chondroitin sulfate. Neuron, 17(6), 1089-1100. doi: 10.1016/S0896-6273(00)80242-1. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/52x6z463

When embryonic thalamic neurons are plated onto living slices of mouse forebrain, cell attachment and neurite outgrowth on different layers of the developing cerebral cortex vary dramatically, in ways that correlate with the timing and pattern of tha

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::bcd67afb9f13c9e7d5a0be8b3f7c3cd9
http://www.escholarship.org/uc/item/52x6z463

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A candidate antibody drug for prevention of malaria.

Autor: Williams KL; Atreca, Inc., San Carlos, CA, USA. kwilliams@atreca.com., Guerrero S; Atreca, Inc., San Carlos, CA, USA., Flores-Garcia Y; Department of Molecular Microbiology and Immunology, Malaria Research Institute, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Kim D; Atreca, Inc., San Carlos, CA, USA.; Initium Therapeutics, Inc., Natick, MA, USA., Williamson KS; Atreca, Inc., San Carlos, CA, USA., Siska C; Just - Evotec Biologics, Seattle, WA, USA., Smidt P; Just - Evotec Biologics, Seattle, WA, USA., Jepson SZ; Just - Evotec Biologics, Seattle, WA, USA., Li K; Duke Center for Human Systems Immunology, Department of Surgery, Duke University, Durham, NC, USA., Dennison SM; Duke Center for Human Systems Immunology, Department of Surgery, Duke University, Durham, NC, USA., Mathis-Torres S; Department of Molecular Microbiology and Immunology, Malaria Research Institute, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Chen X; Atreca, Inc., San Carlos, CA, USA., Wille-Reece U; BioNTech US, Inc., Cambridge, MA, USA.; PATH Center for Vaccine Innovation and Access, Washington DC, USA., MacGill RS; PATH Center for Vaccine Innovation and Access, Washington DC, USA., Walker M; Walker Bioscience, Carlsbad, CA, USA., Jongert E; GSK, Rixensart, Belgium., King CR; PATH Center for Vaccine Innovation and Access, Washington DC, USA., Ockenhouse C; PATH Center for Vaccine Innovation and Access, Washington DC, USA., Glanville J; Centivax, Inc., South San Francisco, CA, USA., Moon JE; Center for Enabling Capabilities, Walter Reed Army Institute of Research, Silver Spring, MD, USA., Regules JA; Walter Reed Army Institute of Research, Silver Spring, MD, USA., Tan YC; Atreca, Inc., San Carlos, CA, USA.; Nuevocor Pte. Ltd, Singapore, Singapore., Cavet G; Atreca, Inc., San Carlos, CA, USA.; Paramune, Inc., San Carlos, CA, USA., Lippow SM; Atreca, Inc., San Carlos, CA, USA., Robinson WH; Division of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA., Dutta S; Walter Reed Army Institute of Research, Silver Spring, MD, USA., Tomaras GD; Duke Center for Human Systems Immunology, Department of Surgery, Duke University, Durham, NC, USA.; Departments of Immunology, Molecular Genetics and Microbiology, Human Vaccine Institute, Duke University, Durham, NC, USA., Zavala F; Department of Molecular Microbiology and Immunology, Malaria Research Institute, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Ketchem RR; Just - Evotec Biologics, Seattle, WA, USA., Emerling DE; Atreca, Inc., San Carlos, CA, USA. danielemerling@biosimplify.com.

Publikováno v: Nature medicine [Nat Med] 2024 Jan; Vol. 30 (1), pp. 117-129. Date of Electronic Publication: 2024 Jan 02.

Convergent antibody evolution and clonotype expansion following influenza virus vaccination.

Autor: Forgacs D; Center for Vaccines and Immunology, University of Georgia, Athens, GA, United States of America., Abreu RB; Center for Vaccines and Immunology, University of Georgia, Athens, GA, United States of America., Sautto GA; Center for Vaccines and Immunology, University of Georgia, Athens, GA, United States of America., Kirchenbaum GA; Center for Vaccines and Immunology, University of Georgia, Athens, GA, United States of America., Drabek E; Atreca, Inc., South San Francisco, CA, United States of America., Williamson KS; Atreca, Inc., South San Francisco, CA, United States of America., Kim D; Atreca, Inc., South San Francisco, CA, United States of America., Emerling DE; Atreca, Inc., South San Francisco, CA, United States of America., Ross TM; Center for Vaccines and Immunology, University of Georgia, Athens, GA, United States of America.; Department of Infectious Diseases, University of Georgia, Athens, GA, United States of America.

Publikováno v: PloS one [PLoS One] 2021 Feb 22; Vol. 16 (2), pp. e0247253. Date of Electronic Publication: 2021 Feb 22 (Print Publication: 2021).

Longitudinal analysis of acute and convalescent B cell responses in a human primary dengue serotype 2 infection model.

Autor: Nivarthi UK; Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599, USA., Tu HA; Department of Microbiology and Molecular Genetics, Vaccine Testing Center, Larner College of Medicine, University of Vermont, Burlington, VT 05405, USA; Cellular, Molecular, and Biomedical Sciences Graduate Program, University of Vermont, Burlington, VT 05405, USA., Delacruz MJ; Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599, USA., Swanstrom J; Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599, USA., Patel B; Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599, USA., Durbin AP; Department of International Health, Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA., Whitehead SS; Laboratory of Infectious Diseases, NIAID, National Institutes of Health, Bethesda, MD 20892, USA., Pierce KK; Department of Microbiology and Molecular Genetics, Vaccine Testing Center, Larner College of Medicine, University of Vermont, Burlington, VT 05405, USA., Kirkpatrick BD; Department of Microbiology and Molecular Genetics, Vaccine Testing Center, Larner College of Medicine, University of Vermont, Burlington, VT 05405, USA., Baric RS; Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599, USA., Nguyen N; Atreca, Inc. Redwood City, California 94063, USA., Emerling DE; Atreca, Inc. Redwood City, California 94063, USA., de Silva AM; Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599, USA. Electronic address: aravinda_desilva@med.unc.edu., Diehl SA; Department of Microbiology and Molecular Genetics, Vaccine Testing Center, Larner College of Medicine, University of Vermont, Burlington, VT 05405, USA. Electronic address: sean.diehl@med.uvm.edu.

Publikováno v: EBioMedicine [EBioMedicine] 2019 Mar; Vol. 41, pp. 465-478. Date of Electronic Publication: 2019 Mar 08.